Ischemic stroke efficacy
Evaluate treatment effects in rodent cerebral ischemia studies using protocol-defined intervention and assessment schedules.
CEREBROVASCULAR MODEL
Rodent MCAO Ischemic Stroke Model
Mouse and rat middle cerebral artery occlusion studies use a suture-occlusion approach to model cerebral ischemia for stroke-focused preclinical research.
The reviewed study documentation identifies both mouse and rat MCAO platforms; the exact strain and procedure design are confirmed for each program.
MODEL OVERVIEW
A rodent cerebral ischemia platform with multimodal phenotyping.
The documented MCAO platform combines filament-based cerebral artery occlusion with imaging, staining, behavioral assessment, and pathology to characterize the ischemic phenotype and treatment response.
Therapeutic areaStroke, Cerebrovascular
SpeciesMouse, Rat
Model formatSuture-occlusion MCAO
Typical useEfficacy, Phenotyping
TYPICAL APPLICATIONS
What this model can support.
Cerebral perfusion assessment
Laser-speckle imaging can be incorporated to visualize changes in cerebral blood-flow patterns around model induction.
Infarct phenotyping
TTC staining provides a tissue-level readout for ischemic injury in the documented model workflow.
Behavior & pathology
Behavioral changes and pathological sections provide complementary functional and tissue-based readouts.
COMMON READOUTS
Readouts selected around the study question.
Endpoints are finalized with the selected model, species or strain, treatment design, and partner laboratory before study placement.
Perfusion
Laser-speckle imaging for cerebral blood-flow visualization and model assessment.
TTC staining
TTC-based assessment of ischemic brain tissue in protocol-defined samples.
Behavior
Behavioral changes assessed according to the selected study protocol.
Pathology
Brain pathological sections for tissue-level evaluation.
The source documentation does not disclose a specific rodent strain. Species, strain, occlusion design, endpoints, and timeline are confirmed during technical review.
STUDY DESIGN
Key factors aligned before execution.
- Mouse or rat study platform
- Occlusion and reperfusion design
- Treatment timing and dosing schedule
- Imaging and behavioral assessment schedule
- TTC and pathology collection plan
- Required PK/PD or biomarker integration
Discuss Your Program
Share the compound, mechanism, development question, preferred model, and intended endpoints. We can review fit, feasibility, and the appropriate partner-laboratory route for a MCAO study.Required fields are marked with an asterisk(*).